Study

LUCENT-1 (NCT 03518086)

ELU-4-58F581-1

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Export as DATS
Types Clinical Trial Ncit:c71104

Datasets

1
  1. Lilly Ulcerative Colitis data

Study description
Primary purpose
Lilly Lucent imaging in Ulcerative Colitis
Study types
Clinical trial NCIT C71104
Description of cohorts
Lucent

Subjects
Organisms
Homo sapiens
Number of subjects
430
Diseases
Ulcerative Colitis
Sample sources
Tissue Sample
Samples collected
Tissue